Literature DB >> 2036292

Trends in sociodemographic and behavioral characteristics of HIV antibody-positive blood donors.

P D Cleary1, N Van Devanter, T F Rogers, E Singer, J Avorn, J Pindyck.   

Abstract

This paper describes the sociodemographic characteristics of people who donated blood to the New York Blood Center between April 1985 and February 1988 and tested positive for antibodies to HIV. Information on HIV-related risk factors and knowledge of blood screening is presented for seropositive donors who participated in an evaluation study. The most commonly reported risk factor among men was sexual contact with another man, and many of the male seropositive donors reported sex with an intravenous (IV) drug user or use of IV drugs. The proportion of men reporting sexual contact with another man decreased over the period of the study, and the proportion reporting use of IV drugs or sex with an IV drug user increased. Awareness of blood screening for HIV antibodies increased over the study period. The greatest increase was among those donating for transfusion, but only about a quarter of seropositive donors used the confidential unit exclusion (CUE) process.

Entities:  

Mesh:

Year:  1991        PMID: 2036292

Source DB:  PubMed          Journal:  AIDS Educ Prev        ISSN: 0899-9546


  3 in total

1.  Depressive symptoms in blood donors notified of HIV infection.

Authors:  P D Cleary; N Van Devanter; T F Rogers; E Singer; R Shipton-Levy; M Steilen; A Stuart; J Avorn; J Pindyck
Journal:  Am J Public Health       Date:  1993-04       Impact factor: 9.308

2.  Behavior changes after notification of HIV infection.

Authors:  P D Cleary; N Van Devanter; T F Rogers; E Singer; R Shipton-Levy; M Steilen; A Stuart; J Avorn; J Pindyck
Journal:  Am J Public Health       Date:  1991-12       Impact factor: 9.308

3.  Efficacy of the confidential unit exclusion option in blood donors in tehran, iran, determined by using the nucleic Acid testing method in 2008 and 2009.

Authors:  Elham Farhadi; Ahmad Gharehbaghian; Gharib Karimi; Shahram Samiee; Farzaneh Tavasolli; Yahya Salimi
Journal:  Hepat Mon       Date:  2011-11-30       Impact factor: 0.660

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.